| Literature DB >> 25314072 |
Abstract
NF-κB protects malignant cells from death and therefore it was considered as a cancer treatment target. However, systemic NF-κB inhibition resulted in inflammation and other undesired outcomes. In this issue of Cancer Cell, Tornatore and colleagues solve this problem by targeting the GADD45:MKK7 module mediating NF-κB-induced survival of multiple myelomas.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25314072 DOI: 10.1016/j.ccell.2014.09.012
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743